PF-Atlas › Clinical Trials › NCT00996424
The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function
Acetylcysteine · Phase 4
Registry ID
NCT00996424
Phase
Phase 4
Status
Terminated
Drug / intervention
Acetylcysteine
Sponsor
University Hospital, Ghent
Start
2010-01
About this trial
Acetylcysteine is evaluated in NCT00996424, a Phase 4 idiopathic pulmonary fibrosis study sponsored by University Hospital, Ghent. Current status: Terminated.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00996424 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.